This study verified AKR1B10 expression and immune infiltration in gastric cancer, and our results consistently demonstrated that AKR1B10 expression was diminished in gastric cancer accompanied with CD19+ B cell proportion decline and CD68+ macrophage increase. This evidence concerns the gene CD19 and gastric cancer.